BI
BVF Inc’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,686,924
| Closed | -$4.05M | – | 65 |
|
|
2024
Q1 | $4.05M | Sell |
1,686,924
-22,748,708
| -93% | -$54.6M | 0.11% | 50 |
|
|
2023
Q4 | $37.4M | Buy |
24,435,632
+4,440,300
| +22% | +$6.79M | 0.94% | 28 |
|
|
2023
Q3 | $21.8M | Hold |
19,995,332
| – | – | 0.59% | 33 |
|
|
2023
Q2 | $45.8M | Buy |
19,995,332
+3,846,153
| +24% | +$8.81M | 1.28% | 23 |
|
|
2023
Q1 | $39.2M | Hold |
16,149,179
| – | – | 1.43% | 23 |
|
|
2022
Q4 | $30.8M | Hold |
16,149,179
| – | – | 1.3% | 28 |
|
|
2022
Q3 | $38.8M | Buy |
16,149,179
+2,000,000
| +14% | +$4.8M | 1.6% | 22 |
|
|
2022
Q2 | $26.3M | Sell |
14,149,179
-207,410
| -1% | -$386K | 1.27% | 27 |
|
|
2022
Q1 | $30M | Sell |
14,356,589
-3,411
| -0% | -$7.13K | 1.2% | 26 |
|
|
2021
Q4 | $56.6M | Hold |
14,360,000
| – | – | 2.05% | 15 |
|
|
2021
Q3 | $69.1M | Buy |
14,360,000
+5,966,000
| +71% | +$28.7M | 2.69% | 9 |
|
|
2021
Q2 | $38.5M | Hold |
8,394,000
| – | – | 1.44% | 17 |
|
|
2021
Q1 | $49.3M | Sell |
8,394,000
-2,569,000
| -23% | -$15.1M | 1.85% | 17 |
|
|
2020
Q4 | $37.5M | Buy |
+10,963,000
| New | +$37.5M | 1.48% | 23 |
|